Gerry Boccarossa, DO in Blountville, TN - Medicare Internal Medicine

Gerry Boccarossa, DO is a medicare enrolled "Internal Medicine" physician in Blountville, Tennessee. His current practice location is 412 Mountain View Ct, Blountville, Tennessee. You can reach out to his office (for appointments etc.) via phone at (423) 220-0650.

Gerry Boccarossa is licensed to practice in Tennessee (license number DO 1162) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1912901760.

Contact Information

	Gerry Boccarossa, DO
	412 Mountain View Ct, Blountville, TN 37617-6252
	(423) 220-0650
	Not Available

Physician's Profile

Full Name	Gerry Boccarossa
Gender	Male
Speciality	Internal Medicine
Location	412 Mountain View Ct, Blountville, Tennessee
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1912901760
Provider Enumeration Date: 06/09/2005
Last Update Date: 09/02/2011

Medicare PECOS Information:

PECOS PAC ID: 6800795741
Enrollment ID: I20200602000832

Medical Identifiers

Medical identifiers for Gerry Boccarossa such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1912901760	NPI	-	NPPES
3304613	Medicaid	TN
005830494	Medicaid	VA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	DO 1162 (Tennessee)	Primary
207R00000X	Internal Medicine	0102201244 (Virginia)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Gerry Boccarossa is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Gerry Boccarossa, DO 412 Mountain View Ct, Blountville, TN 37617-6252 Ph: (423) 220-0650	Gerry Boccarossa, DO 412 Mountain View Ct, Blountville, TN 37617-6252 Ph: (423) 220-0650

News Archive

New urine-based diagnostic method may help detect preeclampsia in pregnant women

A team of scientists from the Federal State Budget Institution "Research Center for Obstetrics, Gynecology and Perinatology", Moscow Institute of Physics and Technology, the Emanuel Institute for Biochemical Physics, and the Talrose Institute for Energy Problems of Chemical Physics have developed an approach for a method of non-invasive testing for pregnant women with a serious and complex condition called preeclampsia.

New research shows mother's milk helps baby to make copies of maternal immune cells

Scientists have long understood that mother's milk provides immune protection against some infectious agents through the transfer of antibodies, a process referred to as "passive immunity."

Surgery not necessary for most late-stage colorectal cancers

A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don't require immediate surgery to remove the primary tumor in the colon. Researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) presented their data at the American Society of Clinical Oncology Annual Meeting.

Diabetes blamed for brain neurochemical abnormalities in bipolar disorder

Diabetes may underlie some of the neurochemical abnormalities observed in the brains of patients with bipolar disorder, say researchers.

Cancer overtreatment raises concern; Physicians tend to use new technology even before solid evidence backs it

The Associated Press/Arizona Republic: "It's an unthinkable notion for a generation raised on the message that early cancer detection saves lives, but specialists say more tumors actually are being found too early. That is raising uncomfortable questions about how aggressively to treat early growths - in some cases, even how aggressively to test - along with a push for more of the informed-choice programs.

Gerry Boccarossa, DO - Medicare Internal Medicine in Blountville, TN